Cargando…
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
We report a retrospective monocentric study performed on 63 patients affected by epilepsy with known etiology, receiving perampanel as add-on therapy with at least 12-month follow-up. The purpose of our study was to evaluate efficacy and tolerability of perampanel in this group of epilepsies. Patien...
Autores principales: | Nilo, Annacarmen, Pauletto, Giada, Gigli, Gian Luigi, Vogrig, Alberto, Dolso, Pierluigi, Valente, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797501/ https://www.ncbi.nlm.nih.gov/pubmed/33458643 http://dx.doi.org/10.1016/j.ebr.2020.100393 |
Ejemplares similares
-
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
por: Vogrig, Alberto, et al.
Publicado: (2022) -
Neurological disorders in COVID-19: a case of Acute Disseminated Encephalomyelitis in an adult patient
por: Verriello, Lorenzo, et al.
Publicado: (2022) -
Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology
por: Miao, Pu, et al.
Publicado: (2023) -
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference?
por: Nilo, Annacarmen, et al.
Publicado: (2023) -
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination
por: Vogrig, Alberto, et al.
Publicado: (2023)